These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16280068

  • 21. Isoflurane post-treatment improves pulmonary vascular permeability via upregulation of heme oxygenase-1.
    Dong X, Hu R, Sun Y, Li Q, Jiang H.
    Exp Lung Res; 2013 Sep; 39(7):295-303. PubMed ID: 23919323
    [Abstract] [Full Text] [Related]

  • 22. Tezosentan attenuates organ injury and mesenteric blood flow decrease in endotoxemia and cecal ligation and puncture.
    Erdem A, Meltem Sevgili A, Akbiyik F, Atilla P, Cakar N, Balkanci ZD, Iskit AB, Guc MO.
    J Surg Res; 2007 Aug; 141(2):211-9. PubMed ID: 17583743
    [Abstract] [Full Text] [Related]

  • 23. Altered capillary filtration coefficient in parathion- and paraoxon-induced edema in isolated and perfused rabbit lungs.
    Delaunois A, Gustin P, Ansay M.
    Toxicol Appl Pharmacol; 1992 Oct; 116(2):161-9. PubMed ID: 1412461
    [Abstract] [Full Text] [Related]

  • 24. sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
    Lundgren J, Kylhammar D, Hedelin P, Rådegran G.
    Acta Physiol (Oxf); 2012 Nov; 206(3):178-94. PubMed ID: 22682645
    [Abstract] [Full Text] [Related]

  • 25. Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use.
    Clozel M, Ramuz H, Clozel JP, Breu V, Hess P, Löffler BM, Coassolo P, Roux S.
    J Pharmacol Exp Ther; 1999 Aug; 290(2):840-6. PubMed ID: 10411600
    [Abstract] [Full Text] [Related]

  • 26. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
    Okamoto I, Abe M, Shibata K, Shimizu N, Sakata N, Katsuragi T, Tanaka K.
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):716-22. PubMed ID: 10934111
    [Abstract] [Full Text] [Related]

  • 27. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
    Chin A, Radhakrishnan J, Fornell L, John E.
    J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
    [Abstract] [Full Text] [Related]

  • 28. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
    Qiu CB, Qiu CS, Hess P, Clozel JP, Clozel M.
    Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
    [Abstract] [Full Text] [Related]

  • 29. Haemodynamic effects of endothelin receptor antagonist, tezosentan, in tumour necrosis factor-alpha treated anaesthetized rats.
    Tabrizchi R, Ford CA.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):156-67. PubMed ID: 12595957
    [Abstract] [Full Text] [Related]

  • 30. Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension.
    Lourenço AP, Vasques-Nóvoa F, Oliveira-Pinto J, Fontoura D, Roncon-Albuquerque R, Leite-Moreira AF.
    Intensive Care Med; 2012 Jun; 38(6):1050-60. PubMed ID: 22349420
    [Abstract] [Full Text] [Related]

  • 31. A newly synthetic vitamin E derivative, E-Ant-S-GS, attenuates lung injury caused by cecal ligation and puncture-induced sepsis in rats.
    Kono Y, Inomata M, Hagiwara S, Shiraishi N, Noguchi T, Kitano S.
    Surgery; 2012 Mar; 151(3):420-6. PubMed ID: 22000829
    [Abstract] [Full Text] [Related]

  • 32. Intravenous glycine after cecal ligation and puncture has no effect on impaired hepatic microperfusion, leukocyte adhesion, and mortality in septic rats.
    Croner RS, Kulu Y, Hoerer E, Peters V, Schmidt-Mader B, Schemmer P, Herfarth C, Klar E.
    Microvasc Res; 2005 Jan; 69(1-2):71-8. PubMed ID: 15797263
    [Abstract] [Full Text] [Related]

  • 33. Mixed endothelin receptor antagonism with tezosentan improves intestinal microcirculation in endotoxemic shock.
    Andersson A, Fenhammar J, Frithiof R, Weitzberg E, Sollevi A, Hjelmqvist H.
    J Surg Res; 2008 Sep; 149(1):138-47. PubMed ID: 18639249
    [Abstract] [Full Text] [Related]

  • 34. Alpha-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats.
    Cadirci E, Altunkaynak BZ, Halici Z, Odabasoglu F, Uyanik MH, Gundogdu C, Suleyman H, Halici M, Albayrak M, Unal B.
    Shock; 2010 May; 33(5):479-84. PubMed ID: 19823117
    [Abstract] [Full Text] [Related]

  • 35. Effects of endothelin antagonist tezosentan on orthodontic tooth movement in rats.
    Drevensek M, Sprogar S, Boras I, Drevensek G.
    Am J Orthod Dentofacial Orthop; 2006 Apr; 129(4):555-8. PubMed ID: 16627184
    [Abstract] [Full Text] [Related]

  • 36. Dibutyryl cAMP prevents increased vascular permeability caused by air embolism in isolated rat lungs.
    Hsu K, Huang KL, Wang D, Hsu CS, Chiang CH.
    Aviat Space Environ Med; 1997 Sep; 68(9):802-6. PubMed ID: 9293348
    [Abstract] [Full Text] [Related]

  • 37. Tezosentan counteracts endotoxin-induced pulmonary edema and improves gas exchange.
    Rossi P, Wanecek M, Konrad D, Oldner A.
    Shock; 2004 Jun; 21(6):543-8. PubMed ID: 15167683
    [Abstract] [Full Text] [Related]

  • 38. Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats.
    Urbanowicz W, Sogni P, Moreau R, Tazi KA, Barriere E, Poirel O, Martin A, Guimont MC, Cazals-Hatem D, Lebrec D.
    Gut; 2004 Dec; 53(12):1844-9. PubMed ID: 15542526
    [Abstract] [Full Text] [Related]

  • 39. Pharmacologic modulation of pulmonary vascular permeability during air embolism.
    Huang KL, Lin YC.
    Undersea Hyperb Med; 1997 Dec; 24(4):315-21. PubMed ID: 9444063
    [Abstract] [Full Text] [Related]

  • 40. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
    Konrad D, Oldner A, Rossi P, Wanecek M, Rudehill A, Weitzberg E.
    Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.